Form 4: USANA Health Sciences Director J Scott Nixon Acquires Restricted Stock Units

J Scott Nixon, a director at USANA Health Sciences, reported the acquisition of 4,230 restricted stock units on May 20, 2025, according to a Form 4 filing with the SEC.

Summary

• On May 20, 2025, J Scott Nixon, a director of USANA Health Sciences Inc., acquired 4,230 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of USNA common stock each.
• The restricted stock units vest in four equal installments: 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
• Following the transaction, Nixon directly owns 4,230 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock unit grants, which is a common practice. It doesn't contain any particularly positive or negative information.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule indicates a multi-stage incentive plan for the director, aligning their interests with the company's performance over the next year.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. The acquisition of restricted stock units is a common form of executive compensation in the health sciences industry.

Stakeholder Impact

• The acquisition of restricted stock units by a director can be viewed positively by shareholders as it aligns management's interests with the company's long-term success.

Key Dates

Keywords

USANA Health Sciences, J Scott Nixon, restricted stock units, Form 4, insider trading, beneficial ownership, USNA